Gapping down
In reaction to disappointing earnings/guidance: CNTY -1.9% (ticking lower).
Other news: PRAN -44.2% (announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease; PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer's disease patients, as measured using PiB-PET Standardized Uptake Value Ratio), MNKD -8.9% (following Afrezza documents on Friday), WHX -5.7% (continued weakness), MX -3.6% (MagnaChip Semi announced that Margaret Sakai has resigned as the Co's Executive Vice President and Chief Financial Officer and from all other officer and director positions with the Co and its subsidiaries, effectively immediately; downgraded to Sell from Neutral at UBS), TPLM -2.5% (Triangle Petroleum subsidiary, RockPile Energy Services, announces upsized credit facility ), HDS -2.5% (filed for 30,000,000 Share common stock offering by holders), BBRY -1.9% (Barron's profiles cautious view on Blackberry; won injunction against Typo Products related to Apple iPhone case, according to reports; upgraded to Hold at Needham but downgraded to Underperform from Neutral at Credit Suisse), GM -1.2% ( moves to secure recalled ignition switches; 824,000 models sold in the U.S. from 2008-2011 will get new ignition switch), GSK -0.7% ( withdraws its application to the EMA for a variation to the Marketing Authorisation for Votrient; presented data from Phase III STABILITY study of darapladib in patients with chronic coronary heart disease; no difference was seen in the treatment groups in the time to first occurrence of MACE ), TGT -0.5% (Trustwave disputes plaintiffs' allegations related to Target data breach).
Analyst comments: .PGTI -1.9% (downgraded to Hold from Buy at Deutsche Bank), MELI -1.3% (initiated with a Sell at Citigroup), CLR -0.5% (downgraded to Accumulate from Buy at KLR Group),
Other news: PRAN -44.2% (announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease; PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer's disease patients, as measured using PiB-PET Standardized Uptake Value Ratio), MNKD -8.9% (following Afrezza documents on Friday), WHX -5.7% (continued weakness), MX -3.6% (MagnaChip Semi announced that Margaret Sakai has resigned as the Co's Executive Vice President and Chief Financial Officer and from all other officer and director positions with the Co and its subsidiaries, effectively immediately; downgraded to Sell from Neutral at UBS), TPLM -2.5% (Triangle Petroleum subsidiary, RockPile Energy Services, announces upsized credit facility ), HDS -2.5% (filed for 30,000,000 Share common stock offering by holders), BBRY -1.9% (Barron's profiles cautious view on Blackberry; won injunction against Typo Products related to Apple iPhone case, according to reports; upgraded to Hold at Needham but downgraded to Underperform from Neutral at Credit Suisse), GM -1.2% ( moves to secure recalled ignition switches; 824,000 models sold in the U.S. from 2008-2011 will get new ignition switch), GSK -0.7% ( withdraws its application to the EMA for a variation to the Marketing Authorisation for Votrient; presented data from Phase III STABILITY study of darapladib in patients with chronic coronary heart disease; no difference was seen in the treatment groups in the time to first occurrence of MACE ), TGT -0.5% (Trustwave disputes plaintiffs' allegations related to Target data breach).
Analyst comments: .PGTI -1.9% (downgraded to Hold from Buy at Deutsche Bank), MELI -1.3% (initiated with a Sell at Citigroup), CLR -0.5% (downgraded to Accumulate from Buy at KLR Group),